showed a trendp = 0.089
Non-CKD patients showed a trend towards numerically higher aldosterone receptor antagonist therapy than CKD patients (31% vs. 13%, p = 0.089).
Non-CKD patients showed a trend towards numerically higher aldosterone receptor antagonist therapy than CKD patients (31% vs. 13%, p = 0.089).
The result of a statistical test was considered significant for p < 0.05, and a statistical trend was defined as p < 0.1.